ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TBIO Telesis Bio Inc

0.3235
0.00 (0.00%)
Pre Market
Last Updated: 04:50:29
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Telesis Bio Inc TBIO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.3235 04:50:29
Open Price Low Price High Price Close Price Prev Close
0.3235
more quote information »

Recent News

Date Time Source Heading
4/18/202409:00GLOBETelesis Bio Inc. announces strategic focus on game-changing..
3/28/202416:05GLOBETelesis Bio Reports Fourth Quarter and Full Year 2023..
3/05/202418:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202418:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202418:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202420:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202420:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202417:00EDGAR2Form 8-K - Current report
2/26/202409:15GLOBETelesis Bio Announces Select Preliminary Fourth Quarter..
11/30/202317:00EDGAR2Form 8-K - Current report
11/13/202316:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202316:32EDGAR2Form 8-K - Current report
11/13/202316:22GLOBETelesis Bio Reports Third Quarter 2023 Financial Results
11/09/202317:00EDGAR2Form 8-K - Current report
11/07/202309:00GLOBETelesis Bio to Report Third Quarter Financial Results on..
11/03/202312:00GLOBETelesis Bio Announces Commercial Release of Cell-free..
10/24/202316:30EDGAR2Form 8-K - Current report
9/28/202315:48GLOBETelesis Bio Announces Commercial Release of BioXp® NGS..
9/22/202317:00EDGAR2Form 8-K - Current report
8/29/202316:05GLOBETelesis Bio Appoints William J. Kullback Chief Financial..
8/29/202316:02EDGAR2Form 8-K - Current report
8/11/202306:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202316:17EDGAR2Form 8-K - Current report
8/10/202316:05GLOBETelesis Bio Reports Second Quarter 2023 Financial Results
8/04/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
8/03/202317:00GLOBETelesis Bio to Report Second Quarter Financial Results on..
7/27/202317:28EDGAR2Form S-3 - Registration statement under Securities Act of..
7/07/202316:01EDGAR2Form 8-K - Current report
6/08/202309:05GLOBETelesis Bio to Present at Jefferies Healthcare Conference..
6/06/202303:00GLOBETelesis Bio to Present at Antibody Engineering and..
6/05/202317:30GLOBETelesis Bio Announces Closing of $28.0 Million Private..
5/31/202317:29GLOBETelesis Bio Secures Financing of $28.0 Million
5/23/202309:00GLOBETelesis Bio to Present at SynBioBeta 2023
5/22/202312:00GLOBETelesis Bio Announces First Commercial Shipment of BioXp®..
5/18/202310:00GLOBETelesis Bio Announces First Commercial Shipment of BioXp®..
5/15/202309:00GLOBETelesis Bio to Present at Protein Engineering Summit (PEGS..
5/11/202316:05GLOBETelesis Bio Reports First Quarter 2023 Financial Results
4/27/202316:05GLOBETelesis Bio to Report First Quarter Financial Results on..

Your Recent History

Delayed Upgrade Clock